BioCube, Inc.
BICB
$0.0002
-$0.0022-91.67%
| 07/31/2013 | 04/30/2013 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 10.82% | -64.58% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 10.82% | -64.58% | |||
| Operating Income | -10.82% | 64.58% | |||
| Income Before Tax | 58.87% | 34.18% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 58.87% | 34.18% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 58.87% | 34.18% | |||
| EBIT | -10.82% | 64.58% | |||
| EBITDA | -149.12% | 284.14% | |||
| EPS Basic | 57.89% | 58.24% | |||
| Normalized Basic EPS | 58.33% | 57.89% | |||
| EPS Diluted | 57.89% | 58.24% | |||
| Normalized Diluted EPS | 58.33% | 57.89% | |||
| Average Basic Shares Outstanding | 0.00% | 57.84% | |||
| Average Diluted Shares Outstanding | 0.00% | 57.84% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
